Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 294


Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.

Panackal AA, Gribskov JL, Staab JF, Kirby KA, Rinaldi M, Marr KA.

J Clin Microbiol. 2006 May;44(5):1740-3.


Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia.

Shin JH, Chae MJ, Song JW, Jung SI, Cho D, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW.

J Clin Microbiol. 2007 Aug;45(8):2385-91. Epub 2007 Jun 20.


In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.

Drago M, Scaltrito MM, Morace G; GISIA-2 Group.

Eur J Clin Microbiol Infect Dis. 2004 Aug;23(8):619-24. Epub 2004 Jul 16.


Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.

Sanglard D, Coste AT.

Antimicrob Agents Chemother. 2015 Oct 19;60(1):229-38. doi: 10.1128/AAC.02157-15. Print 2016 Jan.


Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.

Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Barton R, Bijie H, Bille J, Chang SC, da Luz Martins M, Duse A, Dzierzanowska D, Ellis D, Finquelievich J, Gould I, Gur D, Hoosen A, Lee K, Mallatova N, Mallie M, Peng NG, Petrikos G, Santiago A, Trupl J, VanDen Abeele AM, Wadula J, Zaidi M; Global Antifungal Surveillance Group.

Diagn Microbiol Infect Dis. 2010 Jun;67(2):162-71. doi: 10.1016/j.diagmicrobio.2010.01.002. Epub 2010 Mar 24.


Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.

Chen TC, Chen YH, Chen YC, Lu PL.

Kaohsiung J Med Sci. 2012 Jun;28(6):306-15. doi: 10.1016/j.kjms.2011.11.011. Epub 2012 Apr 4.


Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.

Samra Z, Yardeni M, Peled N, Bishara J.

Eur J Clin Microbiol Infect Dis. 2005 Sep;24(9):592-5.


Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.

Burn AK, Fothergill AW, Kirkpatrick WR, Coco BJ, Patterson TF, McCarthy DI, Rinaldi MG, Redding SW.

J Clin Microbiol. 2004 Dec;42(12):5846-8.


Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.

Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P.

Int J Antimicrob Agents. 2008 Dec;32(6):511-4. doi: 10.1016/j.ijantimicag.2008.05.023. Epub 2008 Sep 13.


Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.

Lee JS, Shin JH, Lee K, Kim MN, Shin BM, Uh Y, Lee WG, Lee HS, Chang CL, Kim SH, Shin MG, Suh SP, Ryang DW.

Yonsei Med J. 2007 Oct 31;48(5):779-86.


Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.

Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G.

Antimicrob Agents Chemother. 2005 Feb;49(2):668-79.


Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.

Gohar AA, Badali H, Shokohi T, Nabili M, Amirrajab N, Moazeni M.

Mycopathologia. 2017 Apr;182(3-4):273-284. doi: 10.1007/s11046-016-0074-8. Epub 2016 Oct 15.


Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole.

Alexander BD, Schell WA, Miller JL, Long GD, Perfect JR.

Transplantation. 2005 Sep 27;80(6):868-71.


Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.

Mann PA, McNicholas PM, Chau AS, Patel R, Mendrick C, Ullmann AJ, Cornely OA, Patino H, Black TA.

Antimicrob Agents Chemother. 2009 Dec;53(12):5026-34. doi: 10.1128/AAC.01031-09. Epub 2009 Sep 28.

Supplemental Content

Support Center